Back
Protalix BioTherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
PLX
Protalix BioTherapeutics
Last Price:
$1.49
Seasonality Move:
-5.81%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.45 | Sell |
| 20-day SMA: | 1.45 | Sell |
| 50-day SMA: | 1.64 | Sell |
| 200-day SMA: | 1.89 | Sell |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 0.73 | Buy |
| 50-day EMA: | 0.35 | Buy |
| 200-day EMA: | 0.1 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 43.26 | Sell |
| Chaikin Money Flow: | 259158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.41 - 1.53) | Sell |
| Bollinger Bands (100): | (1.55 - 2.61) | Sell |
Protalix BioTherapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.43 while PLX 8-day simple moving average is 1.45, which is a Sell signal.
-
The stock price of PLX is 1.43 while Protalix BioTherapeutics 20-day SMA is 1.45, which makes it a Sell.
-
Protalix BioTherapeutics 50-day simple moving average is 1.64 while PLX share price is 1.43, making it a Sell technically.
-
PLX stock price is 1.43 and Protalix BioTherapeutics 200-day simple moving average is 1.89, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
42
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $1.43. The Score for PLX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
113.8M
Price in USD:
1.43
Share Volume:
604.7K
Protalix BioTherapeutics 52-Week Range
52-Week High:
3.10
52-Week Low:
0.82
Sell
42
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 1.43 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.43 while PLX 8-day exponential moving average is 1.18, which is a Buy signal.
-
The stock price of PLX is 1.43 while Protalix BioTherapeutics 20-day EMA is 0.73, which makes it a Buy.
-
Protalix BioTherapeutics 50-day exponential moving average is 0.35 while PLX share price is 1.43, making it a Buy technically.
-
PLX stock price is 1.43 and Protalix BioTherapeutics 200-day simple moving average is 0.10, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Protalix BioTherapeutics is a Buy
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 43.26, which suggest Protalix BioTherapeutics is oversold
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (1.41 - 1.53), which suggest Protalix BioTherapeutics is a Sell
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (1.55 - 2.61), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.